Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
Diabetic RetinopathyOxidative StressDiabetes
Interventions
DRUG

Combined antioxidant therapy

It consists of a tablet with lutein (10 mg), astaxanthin (4 mg), Zeaxanthin (1 mg), vitamin C (L-ascorbic acid 180 mg), vitamin E (DL-alpha tocopherol 30 mg), zinc (zinc oxide 20 mg), copper (copper sulfate 1 mg), taken once a day for 12 months

OTHER

Placebo

It consists in a capsule with 100 mg of magnesium oxide

Trial Locations (1)

44340

Institute of Experimental and Clinical Therapeutics,, Guadalajara

All Listed Sponsors
collaborator

Hospital Civil de Guadalajara

OTHER

lead

University of Guadalajara

OTHER

NCT04071977 - Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients | Biotech Hunter | Biotech Hunter